AMANTA Share Price | Amanta Healthcare Ltd Stock Analysis & Recommendation

Q: Are Amanta Healthcare Ltd latest results good or bad?

Amanta Healthcare Ltd's latest results present a mixed picture. On one hand, the company reported a significant net profit of ₹4.63 crores for Q3 FY26, which is a remarkable 282.64% increase compared to the previous quarter. This surge in profit is primarily attributed to reduced interest costs and improved tax efficiency rather than operational performance, as the revenue growth was more modest at 9.85% year-on-year, reaching ₹74.49 crores.However, the operating margin has contracted by 159 basis points to 20.62%, indicating challenges in maintaining profitability amidst rising costs and competitive pressures. Additionally, while the nine-month net profit has shown a substantial improvement of 73.88% compared to the previous year, this growth has come against a backdrop of only 6.46% revenue expansion.Overall, while the profit growth is impressive, the underlying issues such as margin compression and capital efficiency concerns suggest that the company is facing significant operational challenges. Therefore, while there are positive aspects, the overall outlook remains cautious due to these structural weaknesses.

Q: Should I buy, sell or hold Amanta Healthcare Ltd?

Based on the current analysis of Amanta Healthcare Ltd, it appears that selling may be the prudent choice at this time. The company has demonstrated weak long-term fundamental strength, highlighted by a -2.00% CAGR growth in net sales over the past five years. Additionally, the high Debt to EBITDA ratio of 3.11 times indicates a low ability to service its debt, which can be a significant concern for investors.On the positive side, the company has shown strong performance in the latest quarter, with a notable 73.88% growth in profit after tax and record net sales of Rs 74.49 crore. The operating profit to interest ratio is also impressive at 3.04 times, and the return on capital employed (ROCE) stands at 14, suggesting an attractive valuation.However, the long-term outlook remains uncertain due to the declining sales trend and high debt levels. Therefore, considering these factors, it may be wise to consider selling your shares in Amanta Healthcare Ltd for now.

Q: Why is Amanta Healthcare Ltd falling/rising?

As of 18-Apr, Amanta Healthcare Ltd's stock price is rising, currently at 132.59, reflecting a change of 3.69 (2.86%) upwards. This upward movement can be attributed to several positive factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 18.14% compared to the Sensex's 1.22%. In the last month, the stock has shown an impressive increase of 40.23%, while the Sensex has only risen by 3.18%. Year-to-date, Amanta Healthcare has achieved a return of 21.98%, contrasting sharply with the Sensex's decline of 7.89%.Today's performance indicates that the stock has outperformed its sector by 2.69% and has been on a consecutive gain streak for the last five days, accumulating a total return of 24.51% during this period. The stock reached an intraday high of Rs 133, demonstrating strong investor interest. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement.Investor participation has also increased significantly, with a delivery volume of 4.6 lacs on April 16, which is a remarkable rise of 256.2% compared to the 5-day average delivery volume. This suggests heightened interest and confidence among investors in the stock.Furthermore, the company's financial performance has been strong, with a notable growth in profit after tax (PAT) of 73.88% for the nine-month period, and net sales reaching their highest at Rs 74.49 crore. The operating profit to interest ratio is also at its highest, indicating robust financial health.Overall, the combination of strong recent performance, positive financial results, and increased investor participation are key factors contributing to the rise in Amanta Healthcare Ltd's stock price.

Mojo Score Change: Amanta Healthcar has changed its score on 15 Apr 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

4.62 lacs (3.94%) Volume

Shareholding (Dec 2025)

FII

1.10%

Held by 6 FIIs

DII

7.20%

Held by 5 DIIs

Promoter

63.56%

Are Amanta Healthcare Ltd latest results good or bad?

11-Feb-2026

Amanta Healthcare Ltd's latest results show a significant net profit increase of 282.64% to ₹4.63 crores, but revenue growth is modest at 9.85% and operating margins have contracted, indicating underlying operational challenges. Overall, while profit growth is strong, caution is warranted due to margin compression and capital efficiency concerns.

View full answer

Should I buy, sell or hold Amanta Healthcare Ltd?

08-Apr-2026

Why is Amanta Healthcare Ltd falling/rising?

19-Apr-2026

As of 18-Apr, Amanta Healthcare Ltd's stock price is rising to 132.59, reflecting a 2.86% increase. This growth is driven by strong financial performance, significant investor interest, and consistent outperformance against the benchmark Sensex.

View full answer

Which are the latest news on Amanta Healthcar?

19-Apr-2026

Amanta Healthcare Ltd Upgraded to Hold on Technical and Financial Improvements
Amanta Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

Compare Amanta Healthcar with Similar Stocks

Influx Health.Kilitch Drugs Shree Ganesh Rem

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with a -2.00% CAGR growth in Net Sales over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.11 times

Positive results in Dec 25

With ROCE of 14, it has a Attractive valuation with a 2 Enterprise value to Capital Employed

Majority shareholders : Promoters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 498 Cr (Micro Cap)

P/E

31.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.40

Return on Equity

4.98%

Price to Book

2.34

Revenue and Profits:

Net Sales:

74 Cr

(Quarterly Results - Dec 2025)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

26.16%

6 Months

8.24%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Amanta Healthcare Ltd Upgraded to Hold on Technical and Financial Improvements

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This change reflects a combination of improved technical indicators, positive quarterly financial results, and a more attractive valuation profile, signalling cautious optimism among investors despite some lingering fundamental challenges.

Read full news article

Amanta Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 April 2026. This change reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some encouraging quarterly financial results, the overall outlook has been tempered by weak long-term fundamentals and a shift in technical momentum.

Read full news article

Amanta Healthcare Ltd Upgraded to Hold on Improved Technicals and Financial Performance

Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, driven primarily by a marked improvement in technical indicators and encouraging quarterly financial results. The micro-cap pharmaceutical company’s recent performance reflects a cautiously optimistic outlook amid mixed long-term fundamentals.

Read full news article

Announcements

Clarification On Earlier Disclosure Submitted On April 1St 2026

18-Apr-2026 | Source : BSE

Clarification letter on earlier disclosure submitted on April 1st 2026 pursuant to SEBI (PIT) Regulations 2015

Announcement under Regulation 30 (LODR)-Change in Management

16-Apr-2026 | Source : BSE

Intimation of Resignation of Shri Vimal Shrimali AVP - HR & ADMIN a Senior Management Personnel

Analysts/Institutional Investor Meet/Outcome

09-Apr-2026 | Source : BSE

Analysts/Institutional Investor Meet/Outcome

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.00%

EBIT Growth (5y)

9.30%

EBIT to Interest (avg)

1.30

Debt to EBITDA (avg)

3.27

Net Debt to Equity (avg)

1.99

Sales to Capital Employed (avg)

0.80

Tax Ratio

28.62%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.34%

ROCE (avg)

13.97%

ROE (avg)

8.18%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.44

EV to EBIT

14.50

EV to EBITDA

10.03

EV to Capital Employed

2.03

EV to Sales

2.18

PEG Ratio

Dividend Yield

ROCE (Latest)

14.03%

ROE (Latest)

4.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bullish

Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.99%)

FIIs

Held by 6 FIIs (1.1%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.1%)

Highest Public shareholder

Bandhan Small Cap Fund (3.99%)

Individual Investors Holdings

16.91%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.49",
          "val2": "70.89",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.36",
          "val2": "14.65",
          "chgp": "4.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.06",
          "val2": "5.15",
          "chgp": "-1.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.63",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.63",
          "val2": "1.21",
          "chgp": "282.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.62%",
          "val2": "20.67%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "136.19",
          "val2": "134.83",
          "chgp": "1.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.54",
          "val2": "27.28",
          "chgp": "8.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.44",
          "val2": "15.77",
          "chgp": "-27.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.71",
          "val2": "1.90",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "20.23%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.68",
          "val2": "202.64",
          "chgp": "3.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "44.90",
          "val2": "42.34",
          "chgp": "6.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.50",
          "val2": "21.67",
          "chgp": "-23.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.34",
          "val2": "6.18",
          "chgp": "51.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.31%",
          "val2": "20.89%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.71",
          "val2": "280.34",
          "chgp": "-2.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.67",
          "val2": "57.49",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.95",
          "val2": "33.64",
          "chgp": "-16.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.50",
          "val2": "3.63",
          "chgp": "189.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.72%",
          "val2": "20.51%",
          "chgp": "1.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

74.49

70.89

5.08%

Operating Profit (PBDIT) excl Other Income

15.36

14.65

4.85%

Interest

5.06

5.15

-1.75%

Exceptional Items

0.00

-2.63

100.00%

Standalone Net Profit

4.63

1.21

282.64%

Operating Profit Margin (Excl OI)

20.62%

20.67%

-0.05%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

136.19

134.83

1.01%

Operating Profit (PBDIT) excl Other Income

29.54

27.28

8.28%

Interest

11.44

15.77

-27.46%

Exceptional Items

-2.63

0.00

Standalone Net Profit

4.71

1.90

147.89%

Operating Profit Margin (Excl OI)

21.69%

20.23%

1.46%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

210.68

202.64

3.97%

Operating Profit (PBDIT) excl Other Income

44.90

42.34

6.05%

Interest

16.50

21.67

-23.86%

Exceptional Items

-2.63

0.00

Standalone Net Profit

9.34

6.18

51.13%

Operating Profit Margin (Excl OI)

21.31%

20.89%

0.42%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

274.71

280.34

-2.01%

Operating Profit (PBDIT) excl Other Income

59.67

57.49

3.79%

Interest

27.95

33.64

-16.91%

Exceptional Items

0.00

Standalone Net Profit

10.50

3.63

189.26%

Operating Profit Margin (Excl OI)

21.72%

20.51%

1.21%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Amanta Healthcare Ltd

Amanta Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm "Marck Parenterals (India)" on January 06, 1995. The Company name was changed to "Marck Biosciences Limited" vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005 and was again changed to "Amanta Healthcare Limited" dated June 24, 2014.

Company Coordinates

No Company Details Available